The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.

Saygili, U; Guclu, S; Uslu, T; Erten, O; Dogan, ÖMER

doi:10.1046/j.1525-1438.2002.01171.x

The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.

Saygili U., Guclu S., Uslu T., Erten O., Dogan E.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, cilt.12, sa.5, ss.438-42, 2002 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 5
Basım Tarihi: 2002
Doi Numarası: 10.1046/j.1525-1438.2002.01171.x
Dergi Adı: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.438-42
Anahtar Kelimeler: ascites, CA125, mass volume, ovarian carcinoma, peritoneal carcinomatosis, MONOCLONAL-ANTIBODY, CA-125, CANCER, CYTOREDUCTION, ELEVATION, ANTIGEN, MARKER
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

The aim of this study is to investigate the effects of ascites, ovarian mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with nonmucinous epithelial ovarian carcinoma. Serum CA125 levels were determined by a commercial enzyme immunoassay kit in a series of 98 patients with stage I-IV nonmucinous epithelial ovarian carcinoma. Amounts of ascites were determined in each patient with ascites. Ovarian mass volumes were calculated in 22 patients with stage I disease without ascites. Peritoneal carcinomatosis was detected in 35 ovarian cancer patients. Serum CA125 levels were compared among the patients with different clinical conditions.